US9120812, 254

ID: ALA3940347

Chembl Id: CHEMBL3940347

PubChem CID: 71667456

Max Phase: Preclinical

Molecular Formula: C27H33FN6O4

Molecular Weight: 524.60

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1CC(C)(C)Oc2nc(N3C4CCC3COC4)nc(-c3ccc(NC(=O)NC4CC4)c(F)c3)c2C1=O

Standard InChI:  InChI=1S/C27H33FN6O4/c1-4-33-14-27(2,3)38-23-21(24(33)35)22(31-25(32-23)34-17-8-9-18(34)13-37-12-17)15-5-10-20(19(28)11-15)30-26(36)29-16-6-7-16/h5,10-11,16-18H,4,6-9,12-14H2,1-3H3,(H2,29,30,36)

Standard InChI Key:  JUZWAYFMLNXZNF-UHFFFAOYSA-N

Associated Targets(Human)

MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3R1 Tchem PI3-kinase p85-alpha subunit (279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 524.60Molecular Weight (Monoisotopic): 524.2547AlogP: 3.57#Rotatable Bonds: 5
Polar Surface Area: 108.92Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.37CX Basic pKa: 3.96CX LogP: 3.53CX LogD: 3.53
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.62Np Likeness Score: -1.00

References

1.  (2015)  Pyrimidooxazocine derivatives as mTOR-inhibitors, 

Source

Source(1):